Chi-Un Pae, MD, PhD
- 8Articles
- 18.9KReads
- 2002–2015Active
- 21Collaborators
- 44Citations
About
Chi-Un Pae, MD, PhD, has published extensively on psychiatric conditions including major depressive disorder, anxiety, bipolar disorder, schizophrenia and schizoaffective disorders, and somatoform disorders, with a focus on cognitive dysfunction and treatment approaches. The work encompasses clinical trials and safety analyses of pharmacologic treatments such as milnacipran, selegiline, escitalopram, quetiapine, and olanzapine, as well as investigations into drug augmentation strategies and treatment responses in specific populations, including women. Pae’s contributions span from 2002 to 2015 in peer-reviewed articles addressing both clinical and neuropharmacological aspects of psychiatric illnesses.
Publications
A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease
August 15, 2014
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
